Unmixed Cetuximab from China
EGFR-targeting MAB for cancer. Bulk immunological product HTS 3002.13.00.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Glycan analysis; stability certs; non-retail